Safety and Efficacy of Oral NXC-736 in Adult Participants With Severe Alopecia Areata

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
The purpose of this study is to evaluate the safety and efficacy of NXC-736 monotherapy in participants with severe alopecia areata (AA).
Epistemonikos ID: 9ea27fb715eca2073c6e914284b2e71687a2e378
First added on: May 15, 2024